Marinus Verwijs

Insider Reports History

Location
Boston, MA
Signature
/s/ George A Eldridge, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marinus Verwijs:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. CHIEF TECHNICAL OFFICER Stock Option (Right to Buy) 68,800 $1,126,256 $16.37 14 Jun 2024 Direct
Aerovate Therapeutics, Inc. CHIEF TECHNICAL OFFICER Common Stock 0 $0 $25.00 14 Jun 2024 Direct

Insider Reports Filed by Marinus Verwijs

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JBIO Aerovate Therapeutics, Inc. 14 Jun 2024 3 -$110,346 4 CHIEF TECHNICAL OFFICER 14 Jun 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 02 May 2024 1 -$41,631 4 CHIEF TECHNICAL OFFICER 03 May 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 01 Apr 2024 4 -$77,370 4 CHIEF TECHNICAL OFFICER 03 Apr 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 19 Mar 2024 4 -$60,916 4 CHIEF TECHNICAL OFFICER 20 Mar 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 22 Jan 2024 1 $0 4 CHIEF TECHNOLOGY OFFICER 24 Jan 2024, 18:00
JBIO Aerovate Therapeutics, Inc. 01 Nov 2023 1 -$10,149 4 CHIEF TECHNOLOGY OFFICER 03 Nov 2023, 17:00
JBIO Aerovate Therapeutics, Inc. 03 May 2023 1 -$15,779 4 SENIOR VICE PRESIDENT, CMC 05 May 2023, 18:00
JBIO Aerovate Therapeutics, Inc. 07 Feb 2023 1 $0 4 SENIOR VICE PRESIDENT, CMC 08 Feb 2023, 17:10
JBIO Aerovate Therapeutics, Inc. 02 Nov 2022 1 -$21,346 4 SENIOR VICE PRESIDENT, CMC 03 Nov 2022, 17:00
JBIO Aerovate Therapeutics, Inc. 21 Mar 2022 1 $0 4 Senior Vice President, CMC 23 Mar 2022, 07:47
JBIO Aerovate Therapeutics, Inc. 21 Mar 2022 0 $0 3 Senior Vice President, CMC 23 Mar 2022, 07:45